Nearly one out of every 20 staff in the FDA offices that oversee drugs and biologics are gone after the Trump administration ...

The US Customs and Border Protection warns drugmakers against misrepresenting product values to evade import rules ahead of ...

Kura Oncology said one-quarter of patients with certain forms of advanced acute myeloid leukemia went into complete remission ...

President Donald Trump unofficially asked CMS Administrator Mehmet Oz to lead the administration’s talks with drugmakers to ...

Gilead's Trodelvy shows significant improvement in progression-free survival for metastatic triple-negative breast cancer ...

The Trump administration has been barred from carrying out its sweeping plan to restructure and downsize the Department of ...

Geoffrey Porges, a longtime biotech analyst and well-known Wall Street figure, stepped down as CFO of the New York biotech ...

Volastra reports promising Phase 1/2 data for VLS-1488 in solid tumors, with good safety and early efficacy signals in ...

Plus, news about Sanofi, Servier, BioNova, Arcutis, Roche, Satellos Bioscience, Fore Biotherapeutics, Cinclus Pharma and Zentiva.

Merus completed its rollout of Phase 2 head and neck cancer data on Thursday, touting overall survival results that at least ...

Jazz's Zepzelca + Roche's Tecentriq shows 27% reduced death risk & improved survival in lung cancer trial; FDA application ...

GSK’s blockbuster respiratory drug Nucala was approved Thursday for certain patients with chronic obstructive pulmonary ...